Ferlay, J., Soerjomataram, I., Ervik, M., et al. GLOBOCAN2012v1.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Cited Dec 2013. Lyon, France: International Agency for Research on Cancer, 2013. http://globocan.iarc.fr (accessed May 2018).Google Scholar

Ulbright, T.M., Young, R.H.. Primary mucinous tumors of the testis and paratestis: a report of nine cases. Am J Surg Pathol 2003; 27: 1221–1228.Google Scholar

Funada, S., Yoshida, T., Ito, M., Kono, F., Segawa, T.. Primary borderline mucinous tumors of the testis: a case report and literature review. Case Rep Oncol Med 2015; 2015: 863745.Google Scholar

Jones, M.A., Young, R.H., Srigley, J.R., Scully, R.E.. Paratesticular serous papillary carcinoma: a report of six cases. Am J Surg Pathol 1995; 19: 1359–1365.Google Scholar

Becerra, P., Isaac, M.A., Marquez, B., et al. Papillary serous carcinoma of the tunica vaginalis testis. Pathol Res Pract 2000; 196: 781–782.CrossRefGoogle ScholarPubMed

Remelle, W., Kaiserling, E., Zerban, U., et al. Serous papillary cystic tumor of borderline malignancy with focal carcinoma arising in testis: case report with immunohistochemical and ultrastructural observations. Hum Pathol 1992; 23: 75–79.Google Scholar

Delahunt, B., Nacey, J.N.. Ovarian-type papillary serous cystadenocarcinoma of the testis. Br J Urol 1996; 77: 156–157.Google Scholar

Guarch, R., Rivas, A., Puras, A., Pesce, C.. Papillary serous carcinoma of ovarian type of the testis with borderline differentiation. Histopathology 2005; 46: 587–599.Google Scholar

Maruschke, M., Schmidt, W., Casper, J., Hakenberg, O.W.. Ovarian type surface epithelial carcinoma of the testis with delayed metastatic spread. Urol Int 2008; 81: 119–121.Google Scholar

Young, R.H., Scully, R.E.. Testicular and paratesticular tumors and tumor-like lesions of ovarian common epithelial and mullerian types: a report of four cases and review of the literature. Am J Clin Pathol 1986; 86: 146–152.CrossRefGoogle ScholarPubMed

McClure, R.F., Keeney, G.L., Sebo, T.J., Cheville, J.C.. Serous borderline tumor of the paratestis: a report of seven cases. Am J Surg Pathol 2001; 25: 373–378.Google Scholar

Brito, C.G., Bloch, T., Foster, R.S., Bihrle, R.. Testicular papillary cystadenomatous tumor of low malignant potential: a case report and discussion of the literature. J Urol 1988; 139: 378–379.Google Scholar

Axiotis, C.A.. Intratesticular serous papillary cystadenoma of low malignant potential: an ultrastructural and immunohistochemical study suggesting Mullerian differentiation. Am J Surg Pathol 1988; 12: 56–63.Google Scholar

De Nictolis, M., Tommasoni, S., Fabris, G., Prat, J.. Intratesticular serous cystadenoma of borderline malignancy: a pathological, histochemical and DNA content study of a case with long-term follow-up. Virch Arch A Pathol Anat 1993; 423: 221–225.Google ScholarPubMed

Maruyana, H., Ohyama, N., Hosokawa, Y., et al. Serous borderline tumor of the paratestis. Case report. Pathol Int 2008; 58: 311–316.Google Scholar

McCluggage, W.G., Shah, V., Nott, C., et al. Cystadenoma of spermatic cord resembling ovarian serous epithelial tumour of low malignant potential: immunohistochemical study suggesting Mullerian differentiation. Histopathology 1996; 28: 77–80.Google Scholar

Nistal, M., Revestido, R., Paniagua, R.. Bilateral mucinous cystadenocarcinoma of the testis and epididymis. Arch Pathol Lab Med 1992; 116: 1360–1363.Google ScholarPubMed

Uschuplich, V., Hilsenbeck, J.R., Velasco, C.R.. Paratesticular mucinous cystadenoma arising from an oviduct-like mullerian remnant: a case report and review of the literature. Arch Pathol Lab Med 2006; 130: 1715–1717.Google Scholar

Elliott, J.E., Klein, J.R.H., Drachenberg, D.E.. Primary testicular mucinous neoplasms: case report and literature review. Can Urol Assoc J 2010; 4: E112–E115.Google Scholar

Azuma, T., Matayoshi, Y., Nagase, Y.. Primary mucinous adenocarcinoma of the testis. Case Report Med 2012; 2012: 685946.Google Scholar

Cohen, M., Shawis, R., Evans, C.. Paratesticular Mullerian-type papillary serous tumor in a child. Pediatr Dev Pathol 2009; 12: 297–300.Google Scholar

Caroassai Grisanti, S., Bigazzi, B., Raspollini, M.R., et al. Conservative treatment of serous borderline paratesticular tumor in a pediatric patient. Urology 2016; 89: 123–125.CrossRefGoogle ScholarPubMed

Köbel, M., Kalloger, S.E., Boyd, N., et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 2008; 5: e232.Google Scholar

Mackenzie, R., Talhouk, A., Eshragh, S., et al. Morphological and molecular characteristics of mixed epithelial ovarian carcinomas. Am J Surg Pathol 2015; 39: 1548–1557.Google Scholar

Kurman, R.J., Shin, I.M.. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010; 34: 433–443.CrossRefGoogle ScholarPubMed

Kurman, R.J., Shin, I.M.. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer: shifting the paradigm. Hum Pathol 2011; 42: 918–931.Google Scholar

Arends, M.J., White, E.S., Whitelaw, C.B.A.. Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma. J Pathol 2016; 238: 185–196.Google Scholar

Sato, N., Tsuboda, H., Nishida, M., et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000; 60: 7052–7056.Google Scholar

Seidman, J.D., Yemelyanova, A., Zaino, R.J., Kurman, R.J.. The fallopian tube–peritoneal junction: a potential site of carcinogenesis. Int J Gynecol Pathol 2011; 30: 4–11.CrossRefGoogle ScholarPubMed

Rabban, J.T., Karnezis, A.N., Zaloudek, C.J.. Junctional epithelial zones of the fallopian tube: cancer hotspots? Int J Gynecol Pathol 2011; 30: 1–3.Google Scholar

Piek, J.M., van Diest, P.J., Zweemer, R.P., et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001; 195: 451–456.CrossRefGoogle ScholarPubMed

Swerdlow, M.. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary: case report. Am J Obstet Gynecol 1959; 77: 197–200.Google Scholar

Amin, M.B.. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors. Mod Pathol 2005; 18: S131–S145.Google Scholar

Shimbo, M., Araki, K., Kaibuchi, T., Kuramochi, H., Mori, I.. Mucinous cystadenoma of the testis. J Urol 2004; 172: 146–147.CrossRefGoogle ScholarPubMed

Bürger, T., Schildhaus, H.U., Inniger, R., et al. Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis. Diagn Pathol 2015; 10: 118.Google Scholar

Scully, R.E., Young, R.H., Clement, P.B.. Tumours of the ovary, maldeveloped gonads, fallopian tube and broad legament. In: Rosai, J., Sobin, L.H., editors, Atlas of Tumor Pathology, 3rd edn., Vol 2. Washington, DC: Armed Forces Institute of Pathology; 1998.Google Scholar

Longacre, T.A., McKenney, J.K., Tazelaar, H.D., et al. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol 2005; 29: 707–723.CrossRefGoogle ScholarPubMed

Kosmehl, H., Langbein, L., Kiss, F.. Papillary serous cystoadenoma of the testis. Int Urol Nephrol 1989; 21: 169–174.Google Scholar

Olla, L., Di Naro, N., Puliga, G., et al. Intraparenchymal serous papillary cystadenoma of the testis: a case report. Pathologica 2013; 105: 15–17.Google Scholar

Algaba, F., Mikuz, G., Boccon-Gibod, L., et al. Pseudoneoplastic lesions of the testids and paratesticular structures. Virchows Arch 2007; 451: 987–997.Google Scholar

Morice, P., Uzan, C., Fauvet, R., et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol 2012; 13: e103–e115.Google Scholar

Karlsen, N.M., Karlsen, M.A., Høgdall, E., et al. Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT). Gynecol Oncol 2016; 142(1): 50–53.Google Scholar

Malpica, A., Wong, K.K.. The molecular pathology of ovarian serous borderline tumors. Ann Oncol 2016; 27(Suppl 1): i16–i19.CrossRefGoogle ScholarPubMed

Parker, R.L., Clement, P.B., Chercover, D.J., Sornarajah, T., Gilks, C.B.. Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases. J Gynecol Pathol 2004; 23: 265–272.Google Scholar

Tropé, C.G., Kaern, J., Davidson., B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol 2012; 26: 325–336.Google Scholar

Bell, D.A., Scully, R.E.. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990; 21: 397–403.Google Scholar

McKenney, J.K., Balzer, B.L., Longacre, T.A.. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. Am J Surg Pathol 2006; 30: 1209–1221.Google Scholar

Prat, J., De Nictolis, M.. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002; 26: 1111–1128.Google Scholar

Park, J.Y., Kim, D.Y., Kim, J.H., et al. Micropapillary pattern in serous borderline ovarian tumors: does it matter? Gynecol Oncol 2011; 123: 511–516.Google Scholar

Chang, S.J., Ryu, H.S., Chang, K.H., Yoo, S.C., Yoon, J.H.. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand 2008; 87: 476–481.Google Scholar

Eichhorn, J.H., Bell, D.A., Young, R.H., Scully, R.E.. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999; 23: 397–409.Google Scholar

Wachter, D.L., Wunsch, P.H., Hartmann, A., Agaimy, A.. Adenomatoid tumors of the female and the male genital tract: a comparative clinicopathological and immunohistohemical analysis of 47 cases emphasizing their site-specific morphologic diversity. Virchows Arch 2011; 458: 593–602.Google Scholar

Sangoi, A.R., McKenney, J.K., Schwartz, E.J., et al. Adenomatoid tumors of the female and the male genital tracts: a clinicopathological and immunohistochemical study of 44 cases. Mod Pathol 2009; 22: 1228–1235.Google Scholar

Mutter, G.L., Prat, J.. Pathology of the Female Reproductive Tract, 3rd edn. Dordrecht: Elsevier; 2014.Google Scholar

Colombo, N., Creutzberg, C., Amant, F., et al.; ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 2016; 26: 2–30.CrossRefGoogle ScholarPubMed

Lee, Y.J., Lee, M.Y., Ruan, A., et al. Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms. Oncotarget 2016; 7: 82097–82103.Google Scholar

Perren, T.J.. Mucinous epithelial ovarian carcinoma. Ann Oncol 2016; 27(Suppl 1): i53–i57.CrossRefGoogle ScholarPubMed

Ahmed, R., Din, H.U., Hashmi, S.N., Muhammad, I.. Sarcoma-like mural nodule in a borderline mucinous tumour of ovary. J Coll Physicians Surg Pak 2016; 26: 435–437.Google Scholar

Lee, K.R., Tavassoli, F.A., Prat, J., et al. Tumours of the ovary and peritoneum: surface epithelial-stromal tumours. In: Tavassoli, F.A., Devilee, P., editors, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC; 2003.Google Scholar

Numakura, K., Tsuchiya, N., Tsuruta, H., et al. A case of intratesticular endometrioid papillary cystoadenocarcinoma. Jpn J Clin Oncol 2011; 41: 674–676.Google Scholar

Uzan, C., Dufeu-Lefebvre, M., Fauvet, R., et al. Management and prognosis of clear cell borderline ovarian tumor. Int J Gynecol Cancer 2012; 22: 993–999.Google Scholar

Anglesio, M.S., Carey, M.S., Köbel, M., Mackay, H., Huntsman, D.G.; Vancouver Ovarian Clear Cell Symposium Speakers. Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010. Gynecol Oncol 2011; 121: 407–415.Google Scholar

del Carmen, M.G., Birrer, M., Schorge, J.O.. Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol 2012; 126: 481–490.Google Scholar

Cai, K.Q., Albarracin, C., Rosen, D., et al. Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma. Hum Pathol 2004; 35: 552–559.Google Scholar

Nakonechny, Q.B., Gilks, C.B.. Ovarian cancer in hereditary cancer susceptibility syndromes. Surg Pathol Clin 2016; 9: 189–199.Google Scholar

Takano, M., Kikuchi, Y., Yaegashi, N., et al. Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer 2006; 94: 1369–1374.Google Scholar

Hoskins, P.J., Le, N., Gilks, B., et al. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation. J Clin Oncol 2012; 30: 1656–1662.Google Scholar

Lee, Y.Y., Kim, T.J., Kim, M.J., et al. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis. Gynecol Oncol 2011; 122: 541–547.Google Scholar

Pectasides, D., Pectasides, E., Psyrri, A., Economopoulos, T.. Treatment issues in clear cell carcinoma of the ovary: a different entity? Oncologist 2006; 11: 1089–1094.Google Scholar

Tulunay, O., Gogus, C., Baltaci, S., et al. Clear cell adenocarcinoma of the tunica vaginalis of the testis with an adjcent uterus-like tissue. Pathol Int 2004; 54; 641–647.CrossRefGoogle Scholar

Brenner, F.. Das oophoroma folliculare. Frankfurt Z Path 1907; 1: 150–171.Google Scholar

Kondi-Pafiti, A., Kairi-Vassilatou, E., Iavazzo, Ch., et al. Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors. Arch Gynecol Obstet 2012; 285: 1699–1702.Google Scholar

Kuhn, E., Ayhan, A., Shih, I.M., Seidman, J.D., Kurman, R.J.. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. Eur J Cancer 2013; 49: 3839–3849.Google Scholar

Roma, A.A., Masand, R.P.. Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor. Ann Diagn Pathol 2015; 19: 29–32.Google Scholar

Cuatrecasas, M., Erill, N., Musulen, E., et al. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients. Cancer 1998; 15(82): 1088–1095.Google Scholar

Caccamo, D., Socias, M., Trichet, C.. Malignant Brenner tumor of the testis and epididymis. Arch Pathol Lab Med 1991; 115: 524–527.Google Scholar

Rambau, P.F., McIntyre, J.B., Taylor, J., et al. Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary. Am J Surg Pathol 2017; 41(5): 1.Google Scholar

Scholz, B., Beckert, M., Mordstein, V., et al. Seromucinous borderline tumor of the testis: a case report. Hum Pathol 2017; 60: 188–191.Google Scholar